Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
119 Cards in this Set
- Front
- Back
Potential causes of cellular injury (8)
|
- Hpoxia
- Physical agents - Chemical agents - Nutritional - Genetic (direct or indirect (increasing susceptibility to other diseases) - Workload ibalance - Immunologic |
|
Hpoxia
|
Partial reduction in oxygen supply to cells
|
|
What factors affect the response to cellular injury? (4)
|
Severity, cell type, natre of agent and duration of injury.
|
|
Hyperplasia
|
Increase in number of cells.
|
|
Hypertrophy
|
Increase in size of cells
|
|
Metaplasia
|
One cell type is replaced by another, less well differentiated.
|
|
Squamous metaplasia
|
irritation to respiratory tract causes respiratory epithelium to die. It is replaced by more protective squamous cells. Loss of function.
|
|
Dysplasia
|
Alteration in size, shape and organisation of cells.
|
|
Atrophy
|
Decrease in size of cells.
|
|
Fatty change
|
Accummulation of intracytoplasmic lipid in response to insults which alters the cells ability to metabolise normally.
|
|
Lipidosis
|
Accummulation of fat in cells, taken up from blood in situations of negative energy balance.
|
|
Hydropic degeneration
|
Cellular swelling
|
|
What is hydropic degeneration caused by?
|
Hypoxia
|
|
Pathogenesis of hydropic degeneration?
|
Reduced ATP > switch to anaerobic respiration > depletion of glycogen, build up of lactic acid and inorganic phospahtes > INHIBITION OF NA K PUMP > water moves into cell.
|
|
What is the morphology of cells with hydropic degeneration?
|
Vacuolated cytoplasm.
|
|
In hydropic change, is cell swelling reversible?
|
Yes but can progress to death is stimulus is not removed.
|
|
Which cells are particularly sisceptible to hydropic change?
|
Hepatocytes, renal tubular epithelium, cardiac myocytes, endothelial cells.
|
|
Oncotic necrosis
|
death by swelling. Damaged cells do not necessarily die but if injury is severe/prolonged necrosis occurs due to raised intracellular calcium levels.
|
|
Coagulative necrosis
|
-Characteristic of hypoxic death
- Basic cell outlines are preserved due to delayed proteolysis - acute |
|
Caseous necrosis
|
- Chronic
- Cheese like - Tuberculosis |
|
Liquefactive necrosis
|
- cavities filled with liquefied debris
- Abscesses - found in CNS - little fibrous framework to support dead cells |
|
Gangrenous necrosis
|
- Follows on from coagulative necrosis
- Moist - saprophytes - dry - mummification - gas - saprophytes |
|
Fat necrosis
|
necrosis of fat
|
|
Ischaemia
|
Perfusion is lowered relative to tissues metabolic needs (eg. hypoxia).
|
|
Infarct
|
Localised tissue necrosis resultong from Ischaemia.
|
|
Pyknosis
|
Nucleus is small, shrunken, dense
|
|
Karyorrhexis
|
Nucleus disintergrates (EXPLODES)
|
|
Karyolysis
|
Lysis of nucleus
|
|
Labile cells
|
continuously dividing, eg. bone marrow
|
|
Stable cells
|
Can undergo rapid divison if required, eg. liver cells
|
|
Permanent cells
|
Permanently left cell cycle, cannot undergo meiosis. eg. neurons in CNS
|
|
What are the characteristics of apoptic cells? (3)
|
Chromatin condenses, fragmentation of cytoplasm, apoptic bodies in cytoplasm.
|
|
Necrosis
|
cell death due to traumatic damage - messy
|
|
Apoptosis
|
Cell death managed and programmed.
|
|
Give examples of pruning in embryonic development.
|
- only neurons that reach muscle cells in limb bud will survive, myoblasts secrete neurotrophins which act as survival signals
- Only T-cells with affinity for foreign antigen live, T-cells with no affinity or affinity fro self will be killed. - digits formed by apoptosis of cells between them - mesonephrous duct largely dissappears by apoptosis (embryonic kidney) |
|
What does the paramesonephrous duct develop into? (medial)
|
Fallopian tube
|
|
What does the mesonephric duct develop into? (more lateral)
|
Vas deferens
|
|
How is tissue homeostasis maintained by apoptosis?
|
- liver regenerates itself to original size if it is reduces or increases in size
- cell division and cell death must be balanced - body knows correct size of a tissue |
|
Explain the improtance of apoptosis in virally infected cells?
|
viral antigen shown by APC to T-cell, apoptsis occurs
|
|
Does the cell membrane erupt in apoptsis?
|
Cell membrane does not erupt
|
|
What happens to apoptic cells?
|
They shrink, lose contact with their neighbours, start blebbing and produce apoptic bodies.
|
|
What happens to apoptic bodies?
|
Phagocytosed by other cells.
|
|
In apoptosis the chromosomes condense and do what?
|
Attach to nuclear envelope
|
|
Is there an inflammatory response in apoptosis?
|
No
|
|
What happens in necrosis?
|
Cells swell, cell membrane damaged, loss of cell contents leading to an inflammatory response.
|
|
What do gatekepper caspases do?
|
INfluence many executer caspases leading to an amplification of the signal for apoptosis.
|
|
What are gatekeeper caspases triggered by?
|
Internal and external signals
|
|
Is cell death the default of cells?
|
Yes and it will occur in the abscense of survival signals.
|
|
Caspases
|
Calcium dependent proteases
- cut at aspartic acid residues - activated by proteolytic cascades |
|
What are gatekeeper caspases?
|
PROENZYMES
- require a scaffolding protein for autoactivation |
|
What activates caspase 8?
|
A scaffold assembled at the cell membrane in response to external signals
|
|
What activates caspase 9?
|
A scaffold in the cytoplasm established by cytochrome C release from mitochondria, in response to internal and external signals.
|
|
Apoptosomes
|
Gatekeeper caspase scaffold
|
|
Executer caspases
|
Activated by gatekepper caspases, proteolytic enzymes, produce the changes of apoptosis,
|
|
Uncorrectale DNA damage causes upregulation of what?
|
p53
|
|
What does pro-apoptotic BCl2 do?
|
Forms a pore in mitochondria allowing release of cytochrome C.
|
|
How can apoptosis be initiated? (e.g. via a T-cell receptor and MHC)
|
- Formation of a perforin pore
- via a fas ligand and receptor forming a scaffold for GK caspase 8 |
|
Neoplasia
|
- cancer/tumour
- cells have undergone genetic changes - cells are unresponsive to normal growth controls, - expand beyond normal anatomival boundaries - excessive growth persists even after stimulant is not present. |
|
What causes the genetic changes present in neoplastic cells?
|
- single inherited mutated gene (very rare)
- Multiple inherited genes - acquired somatic mutations |
|
Do Australians breed hereford cows with brown pigmentation around their eyes or no pigmentation?
|
With brown pigmentation - cows without are more susceptible to neoplasms of the eyes/eye cancer. Aussie cows more likely to develop cancer becasue sun increases risk as well.
|
|
Is neoplasm multifactorial or singly factorial?
|
Multifactorial - integrated genes and somatic mutations can play a role.
|
|
Where in the genome do genetic mutations occur? (5)
|
- Growth factors and growth factor receptors.
- Signal transduction proteins (activate cellular growth) - Transcription factors (act directly to increase gene expression) - Anti-oncogenes (tumor suppressors turned off) - DNA repair genes. |
|
Characteristics of benign tumours?
|
Well differentiated,
Uniform cell size/shape Normal nuclear morpology, Few mitoses, Encapsulated, No metastases |
|
Characteristics of malignant tumours?
|
Poorly differentiated,
Variable cell size/shape Abnormal nuclear morphology Increased mitoses Non-encapsulated, infiltrive Metastasises |
|
Anaplastic
|
Poorly differentiated
|
|
PLeomorphic
|
cells are different sizes and shapes
|
|
What do mitoses reflect?
|
Rate of replication (high numer, high rate)
|
|
Which malignant tumours do not metastasize?
|
Tumours of CNS
|
|
what are the direct effects of neoplasia on animals? (5)
|
- compresses tissue,
compresses/blocks blood vessels - block tubular organs - organ rupture haemorrhage |
|
What indirect effets do neoplasms have on animals?
|
remote effects caused by products released by tumour (eg. cachexia)
|
|
Cachexia is an example of what condition?
|
Paraneoplastic syndromes
|
|
Cachexia
|
weight loss and debility, muscle and fat are lost at the same time, feeding up does not help
|
|
What is cachexia likely to be casued by?
|
cytokines, although unknown.
|
|
Haemostasis
|
arressment of bleeding
|
|
Is the haemostatic mechanism always active?
|
yes
|
|
What are the 3 processed involved in haemostasis?
|
1. clumpling of platelets to form a plug.
2. Vasoconstriction to slow escape of blood 3. Formation of a fibrin meshwork or clot |
|
What is plasma?
|
serum with clotting factors, fluid part of blood.
|
|
serum
|
plasma without clotting factors
|
|
Can plasma clot without platelets and blood cells?
|
Yes but it is more rapid in the presence of platelets.
|
|
What are platelets made from?
|
Megakaryocytes
|
|
What shaoe are platelets?
|
Discoid
|
|
What do platelets contain a lot of?
|
Actin and Myosin - this allows them to change shape when they adhere to site of injury = platelet activation, can no longer slip through capillaries.
|
|
Do platelets have a nucleus and organelles?
|
No nucleus but yes they do have organelles. They have a role in secretion - contain glycogen granules.
|
|
How is a plug fromed?
|
Platelets bind to collagen. This requires von Willibrand Factor.
|
|
What does degranulation of platelets release?
|
ATP, ADP, and alpha-serotonin
|
|
What does serotonin do when secreted from platelets?
|
Causes vasoconstriction.
|
|
What activates serotonin?
|
Thrombin
|
|
What does ADP do once released from platelet?
|
Stimulates aggregation of platelets.
|
|
Thromboxane is also formed and released. What does it do?
|
Further stimulates aggregation.
|
|
In which stage is thrombin activated?
|
Third - clot formation
|
|
PLatelets also bring about clot contraction. What is the effect and what does it involve?
|
It pulls the clot tightly against the surface of the vessel. It involves actinomyosin.
|
|
How are platelets self amplifying?
(Include Factor V, fibrinogen and thrombin) |
Platelets provide:
1. Factors - receptors for factor V which is released from alpha granules, promotes thrombin formation. 2. Surface - Factor V must bind to promote thrombin formation, also has receptors fro fibrinogen - thrombin turns this into fibrin which forms the clot. 3. Coagulation localised - all ingredients are attached to platelet. |
|
Arachidonate Metabolites
|
Involved in clot contraction.
Fatty acid with a c=c, flexible produces many messenger molecules |
|
What does prostacyclin do? What does it operate via?
|
Inactivates platelets by inhibiting activation processes. Operates via adenylate cyclase and cAMP.
|
|
What is aspirin
|
anti pain, anti inflammatory drug. Used as a preventative against thrombosis.
|
|
What does aspirin do?
|
Blocks cyclo-oxygenase from forming prostaglandins
Blocks pathway to PGI2 (prostacyclin) and TXA2 (Thromboxine) = in platelets this remains inhbited for life of the cell. = the enzyme in endothelial cells has a more rapid turnover time Increases tendancy to bleed |
|
Are clots static?
|
no, there is a dynamic equilibrium which can be shifted either way.
|
|
Prophylactic anticoagulant
|
preventative - will reduce spread of clot, main value in preventing clots forming
|
|
How can you test DNA to see if it contains an oncogene?
|
It will grow in soft agar/form tumours
|
|
v-onc
|
Viral oncogene
|
|
c-onc
|
Cellular oncogene/pro-oncogene
|
|
How were cellular oncogenes discovered?
|
As part of an oncogenic retrovirus - their names come from the virus (3 letters)
|
|
What is the role of c-oncs?
|
Regulate cellular growth
|
|
When are c-oncs expressed?
|
Generally at the beginning of the cells cycle.
|
|
How do oncogenes exert their effect? (4)
|
1. Products act like GROWTH FACTORS (eg. TGF-beta) - stimulate cells to divide, if over epressed there will be too much growth.
2. Act as GROWTH FACTOR RECEPTORS - stimulate cells to divide. 3. Act as SIGNAL TRANSDUCERS - respond to cell activation by receptor-ligand complexes. (Protein kinase/phosphatase equilibrium disruption can also over enhance signalling). 4. TRANSCRIPTION FACTORS - act directly to increase gene expression. |
|
Antioncogenes
|
Normally repress growth,
|
|
Tumourogenesis - how do oncogenes become disregulated? (3)
|
1. GENE AMPLIFICATION - self perpetuating, changes which confer growth advantages will be selected for.
2. INCREASED EXPRESSION - occurs when the gene is translocated so that it comes under the influence of a strong promoter OR a viral promoter is inserted next to an oncogene. 3. LOSS OF CONTROL FUNCTION - mutation of DNA of oncogene. Oncogene action is controlled by interactions with other proteins/autocatalytic mechanisms which inactivate them - mutations in these will lead to tumourgenesis. (eg. receptor activated even when ligand not present). |
|
mutations of oncogenes are?
|
Dominant
|
|
Mutations of antioncogenes are?
|
Recessive - both alleles must be mutated for cancer to occur.
|
|
Retinoblastoma
|
develop in homozygotes carrying 2 mutant copies of Rb gene - usually occurs by inheritance of a mutated gene and then one somatic mutation.
|
|
What to Rb proteins do?
|
Bind to many c-onc products which exert their effect on the nucleus >> prevents c-oncs from increasing transcription.
|
|
What is the role of p53?
|
Directing the cell towards apoptosis
|
|
How do mutant p53 genes behave?
|
As dominant oncogenes. however, oncogenic property can be inhibited by overproduction of normal p53.
|
|
DNA can be damaged by________ to cause cancer.
|
Chemicals - carcinogens, physically, biologically - viruses.
|
|
Which RNA virus familys cause cancer?
|
Retroviridae, flaviviridae.
|
|
How do RNA viruses transform cells to cause cancer?
|
changes are mediated directly or indirectly by oncogenes of cellular origin.
|
|
How do DNA viruses cause cancer?
|
The transforming genes play essential roles in virus growth, transformed genes are true viral genes.
|
|
In order to induce tansformation what must a virus do?
|
1. express an oncogene as part of its genome
OR 2. Influence the expression of an existing cellular oncogene. |
|
What are the characteristics of a cell altered by tumour viruses (5)
|
altered morphology,
increased growth potential presence of viral DNA, virus specific tumour associated antigens, chromosomal abnormalities |